Applied Molecular Transport to Host Virtual Research & Development Day on October 15, 2021
Management to highlight novel oral biologics technology platform, clinical programs and research activities
Feature distinguished IBD and rheumatology key opinion leaders
Provide update on the four on-going Phase 2 clinical trials for oral AMT-101
SOUTH SAN FRANCISCO, Calif., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that the company will host a virtual Research & Development Day on Friday, October 15, 2021, from 11:00 a.m. – 1:00 p.m. ET. The webcast event will focus on a review of the company’s novel oral biologics technology platform, clinical programs and research activities.
The company’s management team will be joined by IBD and rheumatology key opinion leaders:
Registration for the event as well as a live and archived webcast of the R&D Day will be available on the Events page of the Applied Molecular Transport wesite at https://ir.appliedmt.com/news-events/events.
About Applied Molecular Transport Inc.
AMT’s headquarters, internal GMP manufacturing and lab facilities are located in South San Francisco, CA. For additional information on AMT, please visit www.appliedmt.com.
Investor Relations Contact:
Mobile Edge Compute: Quick and Smart
IoT Evolution Expo #TECHSUPERSHOW Expo Hall Grand Opening
Face the Music: The New Age of Bluetooth